A. González-Jiménez

1.7k total citations
37 papers, 721 citations indexed

About

A. González-Jiménez is a scholar working on Pharmacology, Epidemiology and Molecular Biology. According to data from OpenAlex, A. González-Jiménez has authored 37 papers receiving a total of 721 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pharmacology, 12 papers in Epidemiology and 10 papers in Molecular Biology. Recurrent topics in A. González-Jiménez's work include Drug-Induced Hepatotoxicity and Protection (16 papers), Pharmacogenetics and Drug Metabolism (9 papers) and Liver Disease Diagnosis and Treatment (7 papers). A. González-Jiménez is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (16 papers), Pharmacogenetics and Drug Metabolism (9 papers) and Liver Disease Diagnosis and Treatment (7 papers). A. González-Jiménez collaborates with scholars based in Spain, United States and Argentina. A. González-Jiménez's co-authors include Raúl J. Andrade, M. Isabel Lucena, Inmaculada Medina‐Cáliz, Mercedes Robles‐Díaz, Manuel Romero‐Gómez, Camilla Stephens, Fernando Bessone, Miguel Jiménez‐Pérez, Nelia Hernández and M. Prieto and has published in prestigious journals such as Gastroenterology, The Journal of Clinical Endocrinology & Metabolism and International Journal of Molecular Sciences.

In The Last Decade

A. González-Jiménez

32 papers receiving 705 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. González-Jiménez Spain 11 444 230 160 117 69 37 721
Inmaculada Medina‐Cáliz Spain 17 617 1.4× 280 1.2× 231 1.4× 157 1.3× 90 1.3× 41 986
Eugenia Ulzurrun Spain 9 466 1.0× 178 0.8× 131 0.8× 189 1.6× 86 1.2× 21 674
Lafaine Grant United States 9 310 0.7× 299 1.3× 140 0.9× 82 0.7× 62 0.9× 14 740
Miguel Jiménez‐Pérez Spain 7 266 0.6× 157 0.7× 105 0.7× 75 0.6× 67 1.0× 7 432
M. Carmen Fernández Spain 6 636 1.4× 225 1.0× 166 1.0× 230 2.0× 71 1.0× 7 793
Alain Lemoine France 8 519 1.2× 208 0.9× 197 1.2× 201 1.7× 40 0.6× 21 820
Craig Lammert United States 14 497 1.1× 456 2.0× 433 2.7× 195 1.7× 70 1.0× 55 1.0k
Joaquim Rigau Spain 8 174 0.4× 157 0.7× 129 0.8× 97 0.8× 68 1.0× 10 580
Jaspal Gujral United States 7 286 0.6× 101 0.4× 140 0.9× 76 0.6× 82 1.2× 15 623
Anton Gillessen Germany 14 189 0.4× 151 0.7× 73 0.5× 96 0.8× 148 2.1× 50 905

Countries citing papers authored by A. González-Jiménez

Since Specialization
Citations

This map shows the geographic impact of A. González-Jiménez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. González-Jiménez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. González-Jiménez more than expected).

Fields of papers citing papers by A. González-Jiménez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. González-Jiménez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. González-Jiménez. The network helps show where A. González-Jiménez may publish in the future.

Co-authorship network of co-authors of A. González-Jiménez

This figure shows the co-authorship network connecting the top 25 collaborators of A. González-Jiménez. A scholar is included among the top collaborators of A. González-Jiménez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. González-Jiménez. A. González-Jiménez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mucientes, Arkaitz, Natalia Mena‐Vázquez, Sara Manrique‐Arija, et al.. (2025). Analysis of epigenetic biomarkers for diagnosis and assessment of severity in rheumatoid arthritis: a cross-sectional study. Arthritis Research & Therapy. 27(1). 165–165.
2.
González-Jiménez, A., et al.. (2025). Oral Mucosal Melanoma: Case Reports and Literature Review. International Journal of Oral and Maxillofacial Surgery. 54. 120–121. 1 indexed citations
3.
Niu, Hao, Ismael Álvarez‐Álvarez, Camilla Stephens, et al.. (2025). Epigenetic modifications in drug‐induced liver injury: A systematic review. British Journal of Clinical Pharmacology. 91(6). 1660–1674.
4.
Palacios, Rosario, et al.. (2025). Post-exposure prophylaxis with doxycycline (DoxyPEP) to prevent STIs in a real-world setting: the PRIDOX study. Journal of Antimicrobial Chemotherapy. 80(12). 3306–3310.
5.
Vargas-Molina, Salvador, Mora Murri, A. González-Jiménez, José Luis Gómez‐Urquiza, & Javier Benítez‐Porres. (2024). Effects of the Ketogenic Diet on Strength Performance in Trained Men and Women: A Systematic Review and Meta-Analysis. Nutrients. 16(14). 2200–2200. 3 indexed citations
6.
Benítez‐Porres, Javier, Jorge Rodríguez‐Capitán, A. González-Jiménez, et al.. (2024). A Systematic Review of Proteomics in Obesity: Unpacking the Molecular Puzzle. Current Obesity Reports. 13(3). 403–438. 9 indexed citations
7.
Martínez‐Montoro, José Ignacio, Gracia María Martín‐Núñez, A. González-Jiménez, et al.. (2024). Interactions between the gut microbiome and DNA methylation patterns in blood and visceral adipose tissue in subjects with different metabolic characteristics. Journal of Translational Medicine. 22(1). 1089–1089. 5 indexed citations
8.
Ladehesa-Pineda, Lourdes, Juan Miguel Díaz‐Tocados, Clementina López‐Medina, et al.. (2024). Bone metabolism and inflammatory biomarkers in radiographic and non-radiographic axial spondyloarthritis patients: a comprehensive evaluation. Frontiers in Endocrinology. 15. 1227196–1227196. 4 indexed citations
9.
González-Jiménez, A., et al.. (2024). Epigenetic profiles in blood and adipose tissue: identifying strong correlations in morbidly obese and non-obese patients. Journal of Molecular Medicine. 102(11). 1315–1325.
10.
Sanchez‐Quintero, Maria J., Josué Delgado, Mora Murri, et al.. (2023). Multi-Omics Approach Reveals Prebiotic and Potential Antioxidant Effects of Essential Oils from the Mediterranean Diet on Cardiometabolic Disorder Using Humanized Gnotobiotic Mice. Antioxidants. 12(8). 1643–1643. 7 indexed citations
11.
Gutiérrez‐Repiso, Carolina, et al.. (2023). Epigenetic Marks as Predictors of Metabolic Response to Bariatric Surgery: Validation from an Epigenome Wide Association Study. International Journal of Molecular Sciences. 24(19). 14778–14778. 1 indexed citations
12.
Hayashi, Paul H., M. Isabel Lucena, Robert J. Fontana, et al.. (2022). A revised electronic version of RUCAM for the diagnosis of DILI. Repositorio Institucional de la Universidad de Málaga (University of Málaga). 74 indexed citations
13.
Martínez‐Montoro, José Ignacio, Luís Ocaña-Wilhelmi, A. González-Jiménez, et al.. (2022). Evaluation of Adipose Tissue Zinc-Alpha 2-Glycoprotein Gene Expression and Its Relationship with Metabolic Status and Bariatric Surgery Outcomes in Patients with Class III Obesity. Biomedicines. 10(7). 1502–1502. 3 indexed citations
14.
Mela, Virginia, Patricia Ruiz‐Limón, A. González-Jiménez, et al.. (2022). Mitochondrial Homeostasis in Obesity-related Hypertriglyceridemia. The Journal of Clinical Endocrinology & Metabolism. 107(8). 2203–2215. 5 indexed citations
15.
Gutiérrez‐Repiso, Carolina, A. González-Jiménez, Sergio Valdés, et al.. (2021). Epigenetic Biomarkers of Transition from Metabolically Healthy Obesity to Metabolically Unhealthy Obesity Phenotype: A Prospective Study. International Journal of Molecular Sciences. 22(19). 10417–10417. 10 indexed citations
16.
Zoubek, Miguel Eugenio, Aida Ortega‐Alonso, Nelia Hernández, et al.. (2019). Liver injury after methylprednisolone pulses: A disputable cause of hepatotoxicity. A case series and literature review. United European Gastroenterology Journal. 7(6). 825–837. 30 indexed citations
17.
Zoubek, Miguel Eugenio, A. González-Jiménez, Inmaculada Medina‐Cáliz, et al.. (2017). High Prevalence of Ibuprofen Drug-Induced Liver Injury in Spanish and Latin-American Registries. Clinical Gastroenterology and Hepatology. 16(2). 292–294. 16 indexed citations
18.
Slim, Mahmoud, et al.. (2016). Hepatic Safety of Atypical Antipsychotics: Current Evidence and Future Directions. Drug Safety. 39(10). 925–943. 24 indexed citations
19.
Medina‐Cáliz, Inmaculada, J.M. Navarro, Gloria Isabel Carvajal Peláez, et al.. (2014). Hepatotoxicity associated with statin use: analysis of the cases included in the Spanish Hepatotoxicity Registry.. PubMed. 106(4). 246–54. 53 indexed citations
20.
Robles‐Díaz, Mercedes, M. Isabel Lucena, Neil Kaplowitz, et al.. (2014). Use of Hy's Law and a New Composite Algorithm to Predict Acute Liver Failure in Patients With Drug-Induced Liver Injury. Gastroenterology. 147(1). 109–118.e5. 223 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026